| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$48,437,400 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$48,437,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,427,861 |
2,603,965 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,176,521 |
2,176,521 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-02 |
4 |
OE |
$2.52 |
$621,553 |
D/D |
246,648 |
2,423,169 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
CEO & President |
• – – |
2007-02-01 |
4 |
A |
$12.68 |
$1,902,000 |
D/D |
150,000 |
150,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
OE |
$10.05 |
$1,394,017 |
D/D |
114,666 |
346,030 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2008-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
229,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2009-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
332,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
433,276 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-27 |
4 |
OE |
$14.47 |
$1,236,400 |
D/D |
70,000 |
273,422 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-04 |
4 |
A |
$3.23 |
$186,704 |
D/D |
57,803 |
2,339,452 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
AS |
$203.40 |
$11,119,239 |
D/D |
(54,666) |
286,030 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-25 |
4 |
OE |
$14.47 |
$723,500 |
D/D |
50,000 |
285,310 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-25 |
4 |
AS |
$159.00 |
$7,950,000 |
D/D |
(50,000) |
235,310 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-18 |
4 |
S |
$3.89 |
$194,500 |
D/D |
(50,000) |
2,462,686 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-18 |
4 |
OE |
$3.68 |
$184,000 |
D/D |
50,000 |
2,512,686 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
OE |
$9.96 |
$479,325 |
D/D |
48,125 |
201,739 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,922 |
424,731 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-01-27 |
4 |
AS |
$182.00 |
$7,280,000 |
D/D |
(40,000) |
243,422 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
39,517 |
2,462,686 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-01-10 |
4 |
OE |
$16.14 |
$545,371 |
D/D |
33,790 |
119,209 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-01-19 |
4 |
AS |
$151.92 |
$4,318,902 |
D/D |
(28,099) |
134,200 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2008-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
257,000 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-12-28 |
4 |
A |
$3.66 |
$94,845 |
D/D |
25,914 |
2,397,255 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2009-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
356,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
23,166 |
358,261 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
